From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DoD Improvements to Medical Countermeasure Acquisitions

by Global Biodefense Staff
March 18, 2014

The U.S. Department of Defense (DoD) is seeking input on ways to improve the military’s medical countermeasures development and acquisition approach, to include licensure strategy, solicitation processes, use of small businesses, and contract and program management approaches.

The current licensure strategy extends from early development through the Investigational New Drug (IND) submission whereby the Government acts as an integrator. After IND submission and extending through FDA licensure, the Government seeks a contractor competitively (unless other than full and open competition has been approved) to serve as the integrator (a prime contractor). As the integrator, the prime contractor, acts as sponsor and works collaboratively with the government in all interactions with FDA. Contracted quantities are limited to the needs of the warfighters for the specific product.

The current solicitation process uses Best Value Criteria. Currently, the solicitation requires offerors to submit five proposal volumes (Technical, Past Performance, Administrative, Small Business Participation, and Price/Cost). The technical volume addresses Product Profile, Technical Approach, and Program Management. DoD typically allows 45-60 days after issuance for offerors to submit a proposal. Contract awards usually occur six to nine months after initial proposal receipt.

Contracts can require delivery of FDA approved/licensed products based upon needs of the warfighter, use of the Animal Rule, and complexity of the end product among other things. The portion of the contracts requiring development and licensure of the end product are cost-plus line items requiring offerors have an approved accounting system, while portions of the contracts requiring delivery of initial procurement quantities are Firm Fixed-Price. Contracts also require various data deliverables including, but not limited to: Integrated Master Schedule, Contract Work Breakdown Structure, Technical Data Package, and Drug Master File.

The Government oversees or monitors contractor performance under its contracts by using personnel and methods such as Integrated Product Teams, Earned Value Management Systems, Contracting Officer Representatives and operational and scientific reports.

Under this Request for Information (RFI), interested parties are invited to assist the Government in attracting a broader audience of potential offerors or subcontractors. Specifically, if a different approach was used by the Government in its solicitations and contracts to develop FDA licensed products, what changes in the above would be necessary for your company to be interested in working with the Government.

Respondents may submit questions regarding this RFI or request a meeting through the Point of Contact listed below. All meeting requests may not be granted.

The RFI is managed by the Medical Countermeasure Systems (MCS) Joint Project Management Office (JPMO), under the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD), as the DoD organization responsible for the advanced development, procurement, fielding, and sustaining of medical treatment, prophylactic, and diagnostic capabilities against chemical, biological, radiological, and nuclear warfare agents.

Further details are available under Solicitation Number: W911QY14S0002.

From Our Partners
Tags: JPEO-CBRNDRFI

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC